The importance of the 2024 ISPE Europe Annual Conference is evident with the continuous challenges the pharmaceutical industry is facing in terms of drug shortages, regulatory requirements, digitalization, automation, and big data management.
ISPE announced its fifth annual ISPE/FDA/PQRI Quality Manufacturing Conference, taking place 5 – 7 June in Arlington, Virginia USA. This signature event features a series of concurrent workshops designed to facilitate open dialogue between pharmaceutical industry and regulators to achieve greater alignment on critical quality issues.
“This conference provides the unique opportunity for face-to-face dialogue with regulatory and industry experts in each of the four core workshops,” said John Bournas, ISPE CEO and President. “Attendees can bring their organizations’ quality manufacturing concerns to the table for discussion and help to shape the ongoing dialogue around key industry priorities and best practices.”
A team of pharmaceutical industry and regulatory experts created this year’s program around industry-critical quality initiatives, specifically the 2017 priorities of the FDA Office of Pharmaceutical Quality. Attendees will have the opportunity to hear from key thought leaders throughout the conference on manufacturing quality, compliance, and regulatory global harmonization.
Keynote speakers include:
In addition to keynote and featured presentations, interactive workshops will dominate the conference format, focusing on each one of the 2017 priorities of the FDA Office of Pharmaceutical Quality:
In conjunction with the ISPE/FDA/PQRI Quality Manufacturing Conference, ISPE will be hosting its second annual Data Integrity Workshop on Sunday, 4 June. The half day workshop includes an overview of the topic, a discussion panel, and two sets of three concurrent sessions, providing a unique opportunity for attendees to gain a practical understanding of current data integrity issues and the knowledge necessary to begin to address potential challenges.
Discover the key objectives that will be discussed during the workshop sessions at the ISPE/FDA/PQRI Quality Manufacturing Conference. In addition, learn more about the 2017 ISPE/FDA/PQRI Quality Manufacturing Conference and Data Integrity Workshop by visiting the official event websites.
The importance of the 2024 ISPE Europe Annual Conference is evident with the continuous challenges the pharmaceutical industry is facing in terms of drug shortages, regulatory requirements, digitalization, automation, and big data management.
It is an exciting time in life sciences. Many companies have focused initial artificial intelligence/machine learning (AI/ML) adoption efforts on developing and implementing ML trained algorithms, which necessitate following a controlled approach such as the GAMP® 5 ML Sub-System methodology shown below. This blog highlights key artifacts and considerations when implementing AI/ML for GxP use...
At the 2023 ISPE Pharma 4.0™ and Annex 1 Conference, held 11 – 12 December 2023 in Barcelona, Spain, a panel discussion that included regulators from around the world, as well as industry experts,...